Do you have a personal attachment to Agilent Technologies?

Agilent Technologies, a key player in the Life Sciences Tools & Services sector, is generating buzz among investors looking for promising additions to their portfolios. With a current valuation market value of $133.84, the stock is hovering close to its real value of $135.57, suggesting a fair pricing in the market. Analysts have set a target price range between $123.53 and $150.68, with a consensus leaning towards a "Buy" recommendation. This optimism is bolstered by an EPS estimate of 5.66 for next year, indicating potential growth. However, with a possible downside price of $125.62, investors should weigh the risks alongside the potential rewards. The stock's momentum and balance of power indicators suggest a positive trend, but the mixed analyst ratings, including 10 holds and 1 sell, highlight the need for careful consideration before diving in. Let's dive into what's happening with Agilent Technologies. As of November 24, 2024, the stock is priced at $133.84. Shareholders might see a slight dip in value following the next press release, with the price predicted to decrease marginally to $133.83. Historically, Agilent's stock doesn't react strongly to hype, showing an elasticity of -0.01. The stock's volatility makes it challenging to predict movements based on news or social media alone. The anticipated price drop is minimal at -0.01%, while the daily expected return is currently -0.06%. Looking ahead, the next significant announcement is expected in about eight days, within a 90-day investment horizon.
Published 3 days ago
View all stories for Americafirst Defensive | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Gabriel Shpitalnik

The asset utilization ratio shows how much revenue a company generates for every dollar of assets it holds. Agilent Technologies has a ratio of 63.49%, meaning it earns $0.63 for each dollar of assets. A rising asset utilization ratio indicates that Agilent Technologies is becoming more efficient in using its assets for daily operations.

Main Points

Agilent Technologies, a prominent player in the Diagnostics & Research industry, is catching the eye of savvy investors looking for potential portfolio gems. With its current quote at 133.84 and a modest price change of 1.78, the stock shows a steady, albeit conservative, growth trajectory. Despite its Total Risk Alpha being -0.32, suggesting some volatility, the potential upside of 2.29 keeps the hope alive for those willing to embrace a calculated risk.
The successful prediction of Americafirst Defensive stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Americafirst Defensive Growth, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Americafirst Defensive based on Americafirst Defensive hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Americafirst Defensive's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Americafirst Defensive's related companies.

Use Technical Analysis to project Americafirst expected Price

Americafirst Defensive technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.
A focus of Americafirst Defensive technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Americafirst Defensive trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Sector Allocation

Exchange-Traded Funds use many different techniques to achieve diversification. One of the ways Americafirst Defensive ETF is managing risk is by picking assets from different sectors and across various asset classes. It helps to ensure that returns are uncorrelated, and risk is spread across the underlying asset classes and industries. Within the same asset class, diversification can be achieved by investing in various investment styles through cross-sector allocation. Below map breaks down Americafirst Defensive sector allocation.
Volatility

Instrument Allocation

The asset allocation of funds such as Americafirst Defensive usually varies among a different mix of asset classes. Balanced mutual funds invest not only in bonds, which focus primarily on income, and stocks, which aim for investment growth, but also keep some reserve in cash or even exotic instruments. Below we show the current asset allocation of Americafirst Defensive Growth
Details

Breaking down the case for Americafirst Defensive

The small slip in market price for the last few months could raise concerns from investors as the firm is trading at a share price of 133.84 on very low momentum in volume. The company executives did not add much value to Agilent Technologies investors in October. However, diversifying your holdings with Agilent Technologies or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.61. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.

Current Deferred Revenue Breakdown

Agilent Technologies' Current Deferred Revenue is increasing over the years with slightly volatile fluctuation. Current Deferred Revenue is expected to dwindle to about 364.3 M. Current Deferred Revenue usually refers to revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. At present, Agilent Technologies' Current Deferred Revenue is projected to increase significantly based on the last few years of reporting.
2017
2018
2019
2020
2021
2022
2023
2024
2017324 Million
2018336 Million
2019386 Million
2020441 Million
2021461 Million
2022505 Million
2023580.75 Million
2024364.32 Million
"Buy low, sell high" is a timeless mantra in investing, and Agilent Technologies might just be the opportunity investors are seeking. With a robust market capitalization of $38.46 billion and a Price to Earnings ratio of 37.55X, Agilent stands out in the Diagnostics & Research industry. The company's strong cash flow from operations, totaling $1.77 billion, underscores its financial health and ability to reinvest in growth. Despite a modest profit margin of 0.22%, the potential upside of 2.29 suggests room for appreciation. As investors weigh their options, Agilent's blend of stability and growth potential could make it a compelling addition to a diversified portfolio.

Agilent may start a relapse in December

Agilent Technologies could be facing a downturn as December approaches, with its Coefficient of Variation dropping sharply to -2869.21. This dramatic decline may indicate rising volatility and potential price drops. Investors should monitor this metric closely, as it often points to instability and could signal a tough period ahead for the stock. It's a good time to reassess holdings and consider risk management strategies to handle potential turbulence. Despite this, Agilent shows low volatility, with a skewness of 0.68 and kurtosis of 2.25. Understanding these volatility trends can help investors make informed decisions.
During bear markets, increased volatility can affect Agilent's stock price, prompting investors to adjust their portfolios by diversifying as prices fall.Given the current market dynamics, Agilent Technologies presents an intriguing opportunity for investors. With an analyst consensus rating of "Buy" and a robust EPS estimate of 5.6609 for the next fiscal year ending in October, the stock seems poised for growth. The valuation metrics suggest a slight undervaluation, with the real value pegged at 135.57 compared to its market value of 133.84. Furthermore, the potential upside price of 128.84 offers an attractive entry point for those looking to capitalize on future gains. However, as with any investment, it's essential to stay informed and consider the broader market conditions before making a decision..

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Americafirst Defensive Growth. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com